drugset / Trial / NCT05723406

The Immunomodulatory Effect of Sugammadex After Total Hip Replacement Surgery Under Neuraxial Anaesthesia: a Pilot Study

NCT05723406

Phase 2 Completed 20 enrolled Radboud University Medical Center
RandomizedParallel-groupDouble-blindTreatment

Summary

Monocenter randomized controlled proof of principle study to investigate the effect of sugammadex at the end of total hip replacement surgery on the postoperative innate immune function

Timeline

Start
2023-03-21
Primary completion
2023-11-23
Completion
2023-11-23

Drugs

EvaluationDrugModalityDoseRoute
Subject Sugammadex Other / unclassified 8 mg/kg

Indications